Clinical trial to evaluate combined efficacy of Siravedh with Trayodashanga Guggul in early degeneration of intervertebral disc seen in Sciatica

Open label single group clinical trial to evaluate the combined efficacy of Siravedh with Trayodashanga Guggul in the management of early degeneration of Intervertebral disc seen in sciatica - nil

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/103409

Enrollment

Registered

2026-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: PCS-

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: The patients of age group between 25 to 50 years Patients with classical signs of sciatica patients having SLR test positive

Exclusion criteria

Exclusion criteria: Sciatica due to traumatic injuries Sciatica developed due to post surgical complication Sciatica associated with systemic and meatabolic disorders Potts spine malignancy lumbar spine injury Congenital deformity of vertebral column

Design outcomes

Primary

Measure	Time frame
Lumbar pain,lumbar stiffness,tingling numbness is reduced and range of movement is improved size of intervertebral disc improvedTimepoint: 90 days	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Akshaya Shrikant Rahurkar

CSMSS Ayurved Mahavidyalaya And Rugnalaya

drgadvekayakalp@gmail.com9822682898

Outcome results